Grace Therapeutics Statistics

Total Valuation

GRCE has a market cap or net worth of $33.50 million. The enterprise value is $16.92 million.

Market Cap	33.50M
Enterprise Value	16.92M

Important Dates

The last earnings date was Thursday, February 12, 2026, before market open.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

GRCE has 15.47 million shares outstanding. The number of shares has increased by 36.09% in one year.

Current Share Class	15.47M
Shares Outstanding	15.47M
Shares Change (YoY)	+36.09%
Shares Change (QoQ)	+6.34%
Owned by Insiders (%)	16.53%
Owned by Institutions (%)	14.64%
Float	9.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.55
P/TBV Ratio	2.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.96

Current Ratio	14.96
Quick Ratio	14.56
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -10.22% and return on invested capital (ROIC) is -12.01%.

Return on Equity (ROE)	-10.22%
Return on Assets (ROA)	-10.84%
Return on Invested Capital (ROIC)	-12.01%
Return on Capital Employed (ROCE)	-16.74%
Weighted Average Cost of Capital (WACC)	8.03%
Revenue Per Employee	n/a
Profits Per Employee	-$996,500
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.02M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.69
52-Week Price Change	n/a
50-Day Moving Average	4.10
200-Day Moving Average	3.47
Relative Strength Index (RSI)	28.36
Average Volume (20 Days)	1,432,387

Short Selling Information

The latest short interest is 1.65 million, so 10.68% of the outstanding shares have been sold short.

Short Interest	1.65M
Short Previous Month	1.57M
Short % of Shares Out	10.68%
Short % of Float	16.91%
Short Ratio (days to cover)	3.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-11.25M
Pretax Income	-7.00M
Net Income	-5.98M
EBITDA	-11.24M
EBIT	-11.25M
Earnings Per Share (EPS)	-$0.38

Full Income Statement

Balance Sheet

The company has $18.67 million in cash and n/a in debt, with a net cash position of $18.67 million or $1.21 per share.

Cash & Cash Equivalents	18.67M
Total Debt	n/a
Net Cash	18.67M
Net Cash Per Share	$1.21
Equity (Book Value)	64.89M
Book Value Per Share	4.19
Working Capital	17.93M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-10.13M
Capital Expenditures	n/a
Depreciation & Amortization	7,000
Net Borrowing	n/a
Free Cash Flow	-10.13M
FCF Per Share	-$0.65

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRCE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.09%
Shareholder Yield	-36.09%
Earnings Yield	-16.80%
FCF Yield	-28.46%

Analyst Forecast

The average price target for GRCE is $8.00, which is 269.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	269.52%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 10, 2023. It was a reverse split with a ratio of 1:6.

Last Split Date	Jul 10, 2023
Split Type	Reverse
Split Ratio	1:6

Scores

Altman Z-Score	n/a
Piotroski F-Score	1